Health system strengthening
Health system strengthening
As of December 2017, IFFIm has disbursed US$ 277 million for Gavi's health system strengthening (HSS) support.
As of December 2017, IFFIm has disbursed US$ 277 million for Gavi's health system strengthening (HSS) support
Stable and strong health systems help deliver and scale up new vaccines and improve immunisation coverage and equity.
Gavi, the Vaccine Alliance, supports the world’s poorest countries where health system conditions can vary. Weak health systems represent a significant obstacle to successfully improving routine immunisation coverage. Many factors contribute to weak health systems: inadequate infrastructure, a dearth or lack of trained healthcare workers, an interruption in the supplies of essential commodities, a lack of data to track progress and inadequate facilities to store vaccines throughout the supply chain.
In some Gavi-supported countries, a mother will walk hours in the heat with her newborn child only to be sent home because no trained health worker is available to administer vaccines. The facility can run out of syringes, or a power outage jeopardizes the vaccine cold chain.
Pakistan is one of the countries that has received HSS funds provided to Gavi by IFFIm - more than US$ 16 million. These funds are invested in different areas of the health system to make program management, human resources, finance, logistics, service delivery, monitoring and advocacy more efficient.
Gavi works with countries to develop objectives for each area and supports them to implement activities funded by IFFIm. In order to increase program management performance, for instance, Gavi helps strengthen effective and efficient management structures at national and sub- national levels. In the area of human resources, training and distribution of qualified staff is provided for the immunisation program. In order to guarantee the uninterrupted supply of vaccines to immunisation service delivery, Gavi expands the medical warehouse capacity among other activities.
Another example of IFFIm’s impact through HSS is Nepal. In April 2015, Nepal was shaken by a devastating earthquake that killed approximately 8,000 people and injured more than 21,000. In the aftermath, the country’s healthcare system was strained to the limit. Within days, Nepal managed to resume regular immunisation services. From a hospital in Kathmandu to clinics in the Himalayas, Nepalese national health officials were on the front lines of the disaster, working efficiently and quickly to help people in tents and damaged health facilities.
“It’s really impressive and amazing that Nepal as a country could so rapidly resume their health services including immunisation services,” said Tomoo Hozumi, UNICEF Representative to Nepal. He explains that Nepal’s disaster management was based on strong leadership, action and coordination by the Ministry of Health. This success was only possible due to a stable health administration that had received over US$ 6 million of funds from IFFIm since 2008.
Inactivated polio vaccine launch in Nepal. Credit: Gavi/2014/Oscar Seykens.
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.